Cancer Epigenetics and Oncogenomics

Cancer epigenetics is the study of heritable changes in gene activity or expression without altering the nucleotide sequences in the genetic material. These types of changes include DNA methylation and histone modification in different types of cancer. A variety of epigenetic modifications can be applied such as silencing of tumour suppressor genes or activation of oncogenes, histone modification or dysregulation of DNA binding proteins.

Oncogenomics is a sub-field of genomics that deals with the characterization of cancer related genes. Specifically, it focuses on the genomic, epigenomic and transcriptomic in cancer. It deals with the identification of novel tumour suppressing genes that may be used to find new treatment approach.

    Related Conference of Cancer Epigenetics and Oncogenomics

    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    August 08-09, 2024

    20th World Congress on Healthcare & Technologies

    London, UK
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Paris, France
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France
    November 11-12, 2024

    9th Global Summit on Midwifery and Womens Health

    Dubai, UAE
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    November 25-26, 2024

    4th International conference on Healthcare Summit

    Bali, Indonesia
    November 28-29, 2024

    World Vaccine Meet 2024

    Bali, Indonesia

    Cancer Epigenetics and Oncogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in